Measles-mumps-rubella vaccine at 6  months of age, immunology, and childhood morbidity in a high-income setting: study protocol for a randomized controlled trial
AbstractBackgroundMeasles is a highly contagious and serious infection. Before the introduction of vaccination, measles caused yearly epidemics putting vulnerable children at risk of brain damage and death. Despite safe and cost-effective vaccines, measles remains a leading cause of death in children globally. Due to insufficient vaccine coverage and low levels of in utero transferred antibodies from vaccinated mothers, outbreaks of measles in Denmark and other high-income countries are observed at increasing frequency.The current vaccine was introduced in Denmark in 1987 as a one-shot measles-mumps-rubella vaccine at 15 â...
Source: Trials - December 10, 2020 Category: Research Source Type: clinical trials
A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer
Conditions:  Anatomic Stage IV Breast Cancer AJCC v8;  Invasive Breast Carcinoma;  Metastatic Breast Adenocarcinoma;  Prognostic Stage IV Breast Cancer AJCC v8;  Recurrent Breast Carcinoma Intervention:  Biological: Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein Sponsors:  Mayo Clinic;  National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2020 Category: Research Source Type: clinical trials
Do Childhood Measles and DTaP Vaccination Decrease the Mortality Rate Caused by SARS CoV-2 in OECD Countries?
Conditions:  Covid19;  Measles Vaccine;  Mortality Intervention:  Other: Case fatality rate Sponsor:  Kanuni Sultan Suleyman Training and Research Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2020 Category: Research Source Type: clinical trials
